ETX Diagnostics — UTI Panel
At ETX Diagnostics, we are committed to providing comprehensive, high-accuracy solutions for infection detection and management. Our advanced UTI Panel is designed for the qualitative detection of a wide range of bacterial and fungal pathogens commonly associated with urinary tract infections (UTIs).
Pathogens detected include:
- Acinetobacter baumannii
- Candida albicans
- Klebsiella pneumoniae
- Morganella morganii
- Candida tropicalis
- Citrobacter freundii
- Enterobacter aerogenes (Klebsiella aerogenes)
- Enterobacter cloacae
- Enterococcus faecalis
- Candida glabrata
- Proteus vulgaris
- Enterococcus faecium
- Escherichia coli
- Klebsiella oxytoca
- Proteus mirabilis
- Streptococcus agalactiae (Group B Strep)
- Providencia stuartii
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus saprophyticus
- Candida parapsilosis
- Streptococcus pyogenes
- Ureaplasma urealyticum
Positive samples are automatically reflexed to our Antibiotic Resistance Gene Panel, offering critical insights into potential resistance mechanisms. Our panel detects a broad array of antibiotic resistance genes, including:
- Beta-lactamase genes: ACC, ampC, Class A β-lactamase, blaKPC, blaNDM, CTX-M group 1, SHV, TEM
- Macrolide resistance genes: ErmA, ErmB, ErmC
- Carbapenemase genes: GES, IMP-16, IMP-7, OXA-23, OXA-48
- Methicillin resistance genes: mecA, mecC
- Fluoroquinolone resistance genes: QnrA, QnrS
- Trimethoprim resistance gene: drfA1
- Sulfonamide resistance gene: sul1
- Tetracycline resistance gene: tetM
- Vancomycin resistance genes: VanA, VanB
With rapid and reliable results, ETX Diagnostics’ UTI Panel empowers healthcare providers to make more informed, targeted treatment decisions—improving patient outcomes and supporting antimicrobial stewardship efforts.
Experience precision. Experience ETX Diagnostics.